단백질체학 시장 : 산업 동향 및 세계 예측(-2035년) - 제품 유형별, 장비/기술 유형별, 키트/시약 유형별, 단백질체학 서비스 유형별, 응용 분야별, 최종사용자별, 지역별

Proteomics Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Offering, Type of Instrument / Technology, Type of Kit and Reagent, Type of Proteomics Service, Application Area, End User and Geography

US $ 4,799 ￦ 6,674,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,734,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,741,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 25,033,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

단백질체학 시장 규모는 2024년 316억 달러에 달할 것으로 예상되며, 2024-2035년 예측 기간 동안 10.5%의 CAGR을 기록할 것으로 예상됩니다.

오믹스 기반 분석 분야는 1987년 최초의 인간 유전자 지도가 발견된 이후 큰 진전을 이루었습니다. 오믹스 기반 분석은 세포 내 대규모 생체 분자 집합을 식별, 설명 및 정량화하는 것을 목표로 합니다. 최첨단 오믹스 기술에는 유전체학, 단백질체학, 전사체학, 대사체학 등이 있습니다. 유전체학의 성공은 단백질학의 발전의 길을 열었습니다. 단백질체학은 질병을 분자 수준에서 이해하는 데 있어 매우 중요한 연구 분야가 되었습니다.

단백질체학은 세포, 조직 및 생물체에 포함된 단백질을 대규모로 분석하여 그 구조, 기능 및 상호 작용을 이해하는 것입니다. 이 기술은 세포에서 발현되는 전체 단백질을 분석하여 세포와 조직 내의 역동적인 과정에 대한 깊은 인사이트를 제공합니다. 단백질체학은 질량 분석, 결정 구조 분석, 단백질 마이크로어레이, 바이오인포매틱스 등 첨단 기술을 활용하여 단백질을 분석 및 정량화하여 세포 기능에 대한 종합적인 시각을 제공합니다. 단백질체학의 응용은 질병의 조기 진단을 위한 새로운 바이오마커 발굴, 표적 약물 후보물질 개발, 약물 내성 메커니즘에 대한 전반적인 이해로 이어지고 있습니다. 단백질체학은 복잡한 생물학적 과정과 질병 메커니즘을 밝혀낼 수 있는 잠재력을 가지고 있으며, 생의학 연구와 의료 분야에서 귀중한 도구가 되고 있습니다.

단백질체학 솔루션 제공업체들은 빠르게 발전하는 이 시장의 성장 기회를 활용하기 위해 바이오 제약사, 학술 연구 센터, 연구 기관 등 다양한 고객층에 독자적인 기술을 보급하고 있습니다. 제약사들은 단백질 분석의 민감도, 정확도, 속도를 높이기 위해 단백질 분석 워크플로우에 첨단 하이스루풋 기술과 멀티오믹스 접근법을 도입하고 있습니다. 단일 세포 단백질체학, 공간 단백질체학, 첨단 이미징 기술 등 새로운 기술은 복잡한 세포 불균일성 및 질병 메커니즘을 해독하는 데 활용되고 있습니다. 또한, 인공지능과 머신러닝 알고리즘의 등장으로 데이터 분석이 변화하고 예측 모델링이 가능해지면서 새로운 바이오마커의 발견이 가속화되고 있습니다. 단백질체학 솔루션의 채택이 지속적으로 증가하고 이 분야의 기술 혁신이 지속적으로 이루어짐에 따라, 단백질체학 시장의 성장 기회는 예측 기간 동안 지속될 것으로 예상됩니다.

이 보고서는 세계 단백질체학 시장을 조사했으며, 시장 개요와 함께 제품 유형별, 장비/기술 유형별, 키트/시약 유형별, 단백질체학 서비스 유형별, 응용 분야별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 정리하여 전해드립니다. 등을 제공합니다.

목차

제1장 조사 방법

제2장 경제 및 기타 프로젝트 특유의 고려사항

제3장 주요 요약

제4장 소개

• 단백질체학 개요
• 단백질체학 프로세스에 포함되는 스텝
• 단백질체학 종류
• 단백질체학 응용
• 단백질체학 분야의 과제
• 단백질체학 분야 최신 동향

제5장 시장에 대한 영향 분석 : 촉진요인, 억제요인, 기회, 과제

제6장 세계의 단백질체학 시장

제7장 단백질체학 시장(제공 유형별)

제8장 단백질체학 시장(장비/기술 유형별)

제9장 단백질체학 시장(키트/시약 유형별)

제10장 단백질체학 시장(단백질체학 서비스 유형별)

제11장 단백질체학 시장(응용 분야별)

제12장 단백질체학 시장(최종사용자별)

제13장 단백질체학 시장(지역별)

제14장 시장 상황 : 주요 단백질체학 솔루션 프로바이더

제15장 기업 경쟁력 분석 : 주요 단백질체학 솔루션 프로바이더

제16장 기업 개요 : 북미에 본사를 둔 단백질체학 솔루션 프로바이더

• Agilent Technologies
• Bruker
• Creative Biolabs
• Nautilus Biotechnology
• PerkinElmer
• Seer
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• CellCarta
• Creative Proteomics
• Cytiva
• Promega
• SCIEX
• SomaLogic
• Key Winning Strategies

제17장 기업 개요 : 유럽에 본사를 둔 단백질체학 솔루션 프로바이더

• Merck
• Olink
• Promise Proteomics
• Proteome Factory
• Proteome Sciences
• Key Winning Strategies

제18장 기업 개요 : 아시아태평양에 본사를 둔 단백질체학 솔루션 프로바이더

• Proteomics International
• Macrogen
• Allele Life Sciences
• Bertis
• BGI Genomics
• VProteomics
• Key Winning Strategies

제19장 단백질체학 시장 : 메가트렌드 분석

제20장 밸류체인 분석

제21장 이그제큐티브 인사이트

제22장 부록 1 : 표형식 데이터

제23장 부록 2 : 기업·단체 리스트

ksm

영문 목차

영문목차

The Proteomics Market is valued at USD 31.6 billion in 2024 growing at a CAGR of 10.5% during the forecast period 2024-2035.

The field of omics-based analysis has undergone significant advancements since the discovery of the first human genetic map in 1987. Omics-based analysis aims to identify, describe, and quantify large sets of biological molecules within a cell. The most advanced omics technologies include genomics, proteomics, transcriptomics, and metabolomics. The success of genomics has paved the way for advancements in proteomics, which has become a crucial area of research in understanding diseases at a molecular level.

Proteomics is the large-scale analysis of proteins in a cell, tissue, or organism to understand their structure, function, and interactions. This technology offers deeper insights into the dynamic processes within cells and tissues by analyzing the entire set of proteins expressed by the cell. Proteomics employs advanced technologies such as mass spectrometry, crystallography, protein microarrays, and bioinformatics to analyze and quantify proteins, providing a comprehensive view of cellular functions. The application of proteomics has led to the identification of novel biomarkers for early disease diagnosis, development of targeted drug candidates, and a holistic understanding of drug resistance mechanisms. Proteomics has the potential to unravel the complexities of biological processes and disease mechanisms, making it a valuable tool in biomedical research and healthcare.

To capitalize on the growing opportunity in this rapidly evolving market, proteomics solution providers are improving the penetration of their proprietary technologies within diverse client bases, including biopharma companies, academic research centers, and research institutes. Pharmaceutical companies are integrating advanced high-throughput technologies and multi-omics approaches into their proteomics workflow to enhance sensitivity, accuracy, and speed of protein analysis. Emerging technologies such as single-cell proteomics, spatial proteomics, and advanced imaging techniques are being leveraged to decode complex cellular heterogeneity and disease mechanisms. Additionally, the advent of artificial intelligence and machine learning algorithms is transforming data analysis, enabling predictive modeling, and accelerating the discovery of novel biomarkers As the adoption of proteomics solutions continues to rise and innovation in this domain remains continuous, we expect the opportunity for proteomics market growth to be sustained over the forecast period.

Key Market Segments

Type of Offering

• Instruments
• Kits and Reagents
• Proteomics Services

Type of Instrument / Technology

• Chromatography (Affinity, High -performance Liquid Chromatography, Ion and Supercritical Fluid)
• Electrophoresis (Capillary and Gel Electrophoresis)
• Protein Microarray (Macroarrays and Microchips)
• Spectrometry (Circular Dichroism, Mass Spectroscopy and Nuclear Magnetic Resonance)
• Surface Plasmon Resonance
• X-ray Crystallography
• Other Technologies

Type of Kit and Reagent

• Chromatography Reagents
• Electrophoresis Reagents
• Immunoassay Reagents
• Protein Microarray Reagents
• Spectroscopy Reagents,
• X-ray Crystallography Reagents
• Other Reagents

Type of Proteomics Service

• Bioinformatics Services
• Core Proteomics Services

Application Area

• Diagnostics
• Research (Drug Discovery, and Basic and Translational Research)
• Other Applications

End User

• Academic and Research Institutes
• Clinical Laboratories and Hospitals
• Pharmaceutical and Biotechnology Companies
• Other End users

Geography

• North America (US, Canada and Rest of North America)
• Europe (France, Germany, Italy, Spain, UK and Rest of Europe)
• Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific)
• Latin America (Brazil and Rest of Latin America)
• Middle East and North Africa (Israel and Rest of Middle East and North Africa)
• Rest of the World (South Africa and Rest of the World)

Research Coverage:

• This chapter provides an introductory overview of proteomics, covering the fundamental workflow, various types of proteomics, and its diverse applications. The discussion also highlights the challenges and limitations associated with proteomics. Additionally, the chapter explores the current trends and advancements in the field of proteomics, providing a comprehensive understanding of this rapidly evolving domain.
• A thorough examination of the market for proteomics is presented, encompassing a comprehensive analysis of the factors that may impact its growth. This includes an identification and discussion of key drivers, potential restraints, emerging opportunities, and existing challenges.
• A detailed market analysis is presented, providing an informed estimate of the current market size and future growth potential of the proteomics market over the next decade. This assessment is based on an examination of multiple parameters, including likely adoption trends and validated through secondary and primary research. The report also includes a breakdown of the current and forecasted market opportunity within the proteomics industry, with a focus on the likely distribution of this opportunity. To ensure accuracy and account for potential uncertainties, three forecast scenarios are presented: conservative, base, and optimistic scenarios, which represent different potential tracks of market growth till 2035.
• Comprehensive projections of the current and future opportunity within proteomics market across different types of offering, such as instruments / technologies, kits and reagents, and proteomics services.
• Comprehensive projections of the current and future opportunity within proteomics domain across various types of instruments / technologies, such as chromatography, electrophoresis, protein microarray, spectrometry, surface plasmon resonance, X-ray crystallography, and other technologies.
• Detailed predictions of the current and future opportunity within proteomics industry across various types of kits and reagents, such as chromatography reagents, electrophoresis reagents, immunoassay, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents and other reagents.
• Comprehensive predictions of the current and future opportunity within proteomics market across different types of proteomics services, such as bioinformatics services and core proteomics services.
• Comprehensive projections of the current and future opportunity within proteomics industry across various application areas, such as diagnostics, research and other applications.
• Detailed predictions of the current and future opportunity within proteomics market across different end users, such as academic and research institutes, clinical laboratories and hospitals, pharmaceutical and biotechnology companies and other end users.
• Comprehensive predictions of the current and future opportunity within proteomics industry across various geographies, such as North America (US, Canada and rest of North America), Europe (France, Germany, Italy, Spain, UK and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific), Latin America (Brazil and rest of Latin America), Middle East and North Africa (Israel and rest of Middle East and North Africa) and rest of the world (South Africa and Rest of the World).
• A comprehensive assessment of proteomics solution providers is presented, providing in-depth information on various key parameters. This includes the year of establishment, company size (measured by employee count), and location of headquarters (region and country). Additionally, the report provides details on the type of offering provided by each company, including instruments/technologies, kits and reagents, and proteomics services. The assessment also covers the specific type of instrument or technology involved, such as spectrometry, chromatography, electrophoresis, protein microarray, X-ray crystallography, surface plasmon resonance, and other technologies. Furthermore, the report examines the type of solution offered by each company, including core proteomics solutions and bioinformatics solutions. Finally, the assessment focuses on the application area of each company's offerings, including research and clinical diagnostics.
• A comprehensive competitiveness analysis is conducted to evaluate the strengths and weaknesses of proteomics solution providers. This analysis is based on several key parameters, including developer strength, which is measured by the number of years of experience of a company and its company size. Additionally, the report examines portfolio diversity, encompassing the number of types of offerings, solutions offered, and application areas served. The competitiveness analysis provides a detailed assessment of the competitive landscape, highlighting the unique strengths and focus areas of each company. Furthermore, the report presents a benchmarking analysis, comparing the existing capabilities of these companies against their competitors, to identify areas of differentiation and potential opportunities for growth. This in-depth analysis enables stakeholders to gain a deeper understanding of the competitive dynamics within the proteomics industry and make informed decisions about their strategic directions.
• Comprehensive profiles of leading players in the proteomics market. Each profile features a brief overview of the company (including information on year of establishment, location of headquarters, number of employees, management team, contact details and business segments), proteomics-related offerings, financial information, recent developments and an informed future outlook.
• A comprehensive qualitative assessment of the several megatrends ongoing in the proteomics industry, including the advancements in novel mass spectrometers, development of bioinformatics tools and big data, label-free quantification techniques, incorporation of artificial intelligence and machine leaning, integration with multi-omics, emergence of single cell proteomics and proteogenomics, applications in precision medicine, and the evolving regulatory guidelines.
• A comprehensive value chain analysis is conducted to examine the various stakeholders involved in the proteomics process, encompassing the entire spectrum from suppliers to end-users. This examination provides a detailed understanding of the complex relationships and interactions that shape the proteomics industry.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Proteomics Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• Agilent
• Allele Life Sciences
• Bertis
• BGI Genomics
• Bio-Rad Laboratories
• Bruker Corporation
• CellCarta
• Creative Biolabs
• Creative proteomics
• Cytiva
• Macrogen
• Merck
• Nautilus
• Olink
• PerkinElmer
• Promega
• Promise Proteomics
• Proteome Factory
• Proteome Sciences
• Proteomics International

SCIEX

• Seer
• SomaLogic
• Thermo Fisher Scientific
• VProteomics

TABLE OF CONTENTS

1. RESEARCH METHODOLOGY

• 1.1. Chapter Overview
• 1.2. Research Assumptions
• 1.3. Project Methodology
• 1.4. Forecast Methodology
• 1.5. Robust Quality Control
• 1.6. Key Market Segmentations
• 1.7. Key Considerations
  • 1.7.1. Demographics
  • 1.7.2. Economic Factors
  • 1.7.3. Government Regulations
  • 1.7.4. Supply Chain
  • 1.7.5. COVID Impact
  • 1.7.6. Market Access
  • 1.7.7. Healthcare Policies
  • 1.7.8. Industry Consolidation

2. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

• 2.1. Chapter Overview
• 2.2. Market Dynamics
  • 2.2.1. Time Period
    • 2.2.1.1. Historical Trends
    • 2.2.1.2. Current and Forecasted Estimates
  • 2.2.2. Currency Coverage and Foreign Exchange Rate
    • 2.2.2.1. Major Currencies Affecting the Market
    • 2.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
    • 2.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
    • 2.2.2.4. Strategies For Mitigating Foreign Exchange Risk
  • 2.2.3. Trade Policies
    • 2.2.3.1. Impact of Trade Barriers on the Market
    • 2.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
  • 2.2.4. Recession
    • 2.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
    • 2.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
  • 2.2.5. Inflation
    • 2.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
    • 2.2.5.2. Potential Impact of Inflation on the Market Evolution

3. EXECUTIVE SUMMARY

4. INTRODUCTION

• 4.1. An Overview of Proteomics
• 4.2. Steps involved in Proteomics Process
• 4.3. Types of Proteomics
• 4.4. Applications of Proteomics
• 4.5. Challenges in Proteomics Domain
• 4.6. Recent Trends in Proteomics Domain

5. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

• 5.1. Market Drivers
• 5.2. Market Restraints
• 5.3. Market Opportunities
• 5.4. Market Challenges

6. GLOBAL PROTEOMICS MARKET

• 6.1. Key Assumptions and Methodology
• 6.2. Global Proteomics Market, till 2035
  • 6.2.1. Scenario Analysis
    • 6.2.1.1. Conservative Scenario
    • 6.2.1.2. Optimistic Scenario

7. PROTEOMICS MARKET, BY TYPE OF OFFERING

• 7.1. Key Assumptions and Methodology
• 7.2. Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035
  • 7.2.1. Proteomics Market for Instruments / Technologies, till 2035
  • 7.2.2. Proteomics Market for Kits and Reagents, till 2035
  • 7.2.3. Proteomics Market for Proteomics Services, till 2035

8. PROTEOMICS MARKET, BY TYPE OF INSTRUMENT / TECHNOLOGY

• 8.1. Key Assumptions and Methodology
• 8.2. Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035
  • 8.2.1. Proteomics Market for Chromatography, till 2035
    • 8.2.1.1. Proteomics Market for Affinity Chromatography, till 2035
    • 8.2.1.2. Proteomics Market for High Performance Liquid Chromatography, till 2035
    • 8.2.1.3. Proteomics Market for Ion Chromatography, till 2035
    • 8.2.1.4. Proteomics Market for Supercritical Fluid Chromatography, till 2035
  • 8.2.2. Proteomics Market for Electrophoresis, till 2035
    • 8.2.2.1. Proteomics Market for Proteomics Market for Capillary Electrophoresis, till 2035
    • 8.2.2.2. Proteomics Market for Proteomics Market for Gel Electrophoresis, till 2035
  • 8.2.3. Proteomics Market for Protein Microarrays, till 2035
    • 8.2.3.1. Proteomics Market for Microarrays, till 2035
    • 8.2.3.2. Proteomics Market for Microchips, till 2035
  • 8.2.4. Proteomics Market for Spectrometry, till 2035
    • 8.2.4.1. Proteomics Market for Circular Dichroism, till 2035
    • 8.2.4.2. Proteomics Market for Mass Spectroscopy, till 2035
    • 8.2.4.3. Proteomics Market for Nuclear Magnetic Resonance, till 2035
  • 8.2.5. Proteomics Market for Surface Plasmon Resonance, till 2035
  • 8.2.6. Proteomics Market for X-ray Crystallography, till 2035
  • 8.2.7. Proteomics Market for Other Technologies, till 2035

9. PROTEOMICS MARKET, BY TYPE OF KIT AND REAGENT

• 9.1. Key Assumptions and Methodology
• 9.2. Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035
  • 9.2.1. Proteomics Market for Chromatography Reagents, till 2035
  • 9.2.2. Proteomics Market for Electrophoresis Reagents, till 2035
  • 9.2.3. Proteomics Market for Immunoassay Reagents, till 2035
  • 9.2.4. Proteomics Market for Protein Microarray Reagents, till 2035
  • 9.2.5. Proteomics Market for X-ray Crystallography Reagents, till 2035
  • 9.2.6. Proteomics Market for Other Reagents, till 2035

10. PROTEOMICS MARKET, BY TYPE OF PROTEOMICS SERVICE

• 10.1. Key Assumptions and Methodology
• 10.2. Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035
  • 10.2.1. Proteomics Market for Bioinformatics Services, till 2035
  • 10.2.2. Proteomics Market for Core Proteomics Services, till 2035

11. PROTEOMICS MARKET, BY APPLICATION AREA

• 11.1. Key Assumptions and Methodology
• 11.2. Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035
  • 11.2.1. Proteomics Market for Diagnostics, till 2035
  • 11.2.2. Proteomics Market for Research: Till 2035
    • 11.2.2.1 Proteomics Market for Basic and Translational Research, till 2035
    • 11.2.2.2. Proteomics Market for Drug Discovery, till 2035
  • 11.2.3. Proteomics Market for Other Applications, till 2035

12. PROTEOMICS MARKET, BY END USER

• 12.1. Key Assumptions and Methodology
• 12.2. Proteomics Market: Distribution by Type of End User, 2020, 2024 and 2035
  • 12.2.1. Proteomics Market for Academic and Research Institutes, till 2035
  • 12.2.2. Proteomics Market for Clinical Laboratories and Hospitals, till 2035
  • 12.2.3. Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035
  • 12.2.4. Proteomics Market for Other End Users, till 2035

13. PROTEOMICS MARKET, BY GEOGRAPHY

• 13.1. Key Assumptions and Methodology
• 13.2. Proteomics Market: Distribution by Geography, 2020, 2024 and 2035
  • 13.2.1. Proteomics Market in North America, till 2035
    • 13.2.1.1. Proteomics Market in the US, till2035
    • 13.2.1.2. Proteomics Market in Canada, till2035
    • 13.2.1.3. Proteomics Market in Rest of North America, till2035
  • 13.2.2. Proteomics Market in Europe, till2035
    • 13.2.2.1. Proteomics Market in Germany, till2035
    • 13.2.2.2. Proteomics Market in France, till2035
    • 13.2.2.3. Proteomics Market in the UK, till 2035
    • 13.2.2.4. Proteomics Market in Italy, till 2035
    • 13.2.2.5. Proteomics Market in Spain, till 2035
    • 13.2.2.6. Proteomics Market in Rest of Europe, till 2035
  • 13.2.3. Proteomics Market in Asia-Pacific, till 2035
    • 13.2.3.1. Proteomics Market in South Korea, till 2035
    • 13.2.3.2. Proteomics Market in China, till 2035
    • 13.2.3.3. Proteomics Market in Japan, till 2035
    • 13.2.3.4. Proteomics Market in India, till 2035
    • 13.2.3.5. Proteomics Market in Rest of Asia-Pacific, till 2035
  • 13.2.4. Proteomics Market in Latin America, till 2035
    • 13.2.4.1. Proteomics Market in Brazil, till 2035
    • 13.2.4.2. Proteomics Market in Rest of Latin America, till 2035
  • 13.2.5. Proteomics Market in Middle East and North Africa, till 2035
    • 13.2.5.1. Proteomics Market in Israel, till 2035
    • 13.2.5.2. Proteomics Market in Rest of Middle East and North Africa, till 2035
  • 13.2.6. Proteomics Market in Rest of the World, till 2035
    • 13.2.6.1. Proteomics Market in South Africa, till 2035
    • 13.2.6.2. Proteomics Market in Other Countries, till 2035

14. MARKET LANDSCAPE: KEY PROTEOMICS SOLUTION PROVIDERS

• 14.1. Key Proteomics Solution Providers: Overall Market Landscape
  • 14.1.1. Analysis by Year of Establishment
  • 14.1.2. Analysis by Company Size
  • 14.1.3. Analysis by Location of Headquarters (Region)
  • 14.1.4. Analysis by Location of Headquarters (Country)
  • 14.1.5. Analysis by Type of Offering
  • 14.1.6. Analysis by Type of Instrument / Technology Involved
  • 14.1.7. Analysis by Type of Solution Offered
  • 14.1.8. Analysis by Application Area

15. COMPANY COMPETITIVENESS ANALYSIS: KEY PROTEOMICS SOLUTION PROVIDERS

• 15.1. Key Parameters and Methodology
• 15.2. Company Competitiveness Analysis: Key Proteomics Solution Providers
• 15.3. Benchmarking Analysis of Key Proteomics Solution Providers
  • 15.3.1. Spider Web Analysis: Benchmarking of Key Players
  • 15.3.2. Parameter-wise Benchmarking of Proteomics Solution Providers
    • 15.3.2.1. By Years of Experience
    • 15.3.2.2. By Company Size
    • 15.3.2.3. By Application Area
    • 15.3.2.4. By Number of Offerings
    • 15.3.2.5. By Number of Instruments / Technologies
    • 15.3.2.6. By Number of Solutions Offered

16. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN NORTH AMERICA

• 16.1. Agilent Technologies
  • 16.1.1. Company Details
  • 16.1.2. Proteomics-related Offerings
  • 16.1.3. Financial Details
  • 16.1.4. Recent Developments and Future Outlook
• 16.2. Bruker
• 16.3. Creative Biolabs
• 16.4. Nautilus Biotechnology
• 16.5. PerkinElmer
• 16.6. Seer
• 16.7. Thermo Fisher Scientific
• 16.8. Bio - Rad Laboratories
• 16.9. CellCarta
• 16.10. Creative Proteomics
• 16.11. Cytiva
• 16.12. Promega
• 16.13. SCIEX
• 16.14. SomaLogic
• 16.15. Key Winning Strategies

17. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN EUROPE

• 17.1. Merck
  • 17.1.1. Company Details
  • 17.1.2. Proteomics-related Offerings
  • 17.1.3. Financial Details
  • 17.1.4. Recent Developments and Future Outlook
• 17.2. Olink
• 17.3. Promise Proteomics
• 17.4. Proteome Factory
• 17.5. Proteome Sciences
• 17.6. Key Winning Strategies

18. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN ASIA-PACIFIC

• 18.1. Proteomics International
  • 18.1.1. Company Details
  • 18.1.2. Proteomics-related Offerings
  • 18.1.3. Financial Details
  • 18.1.4. Recent Developments and Future Outlook
• 18.2. Macrogen
• 18.3. Allele Life Sciences
• 18.4. Bertis
• 18.5. BGI Genomics
• 18.6. VProteomics
• 18.7. Key Winning Strategies

19. PROTEOMICS MARKET: MEGATRENDS ANALYSIS

• 19.1. Megatrends in the Proteomics Market
  • 19.1.1. Advancements of Novel Mass Spectrometers
  • 19.1.2. Development of Bioinformatics Tools and Big Data
  • 19.1.3. Label-free Quantification Techniques
  • 19.1.4. Adoption of Artificial Intelligence and Machine Leaning
  • 19.1.5. Integration of Multi-omics
  • 19.1.6. Emergence of Single Cell Proteomics and Proteogenomics
  • 19.1.7. Applications in Precision Medicine
  • 19.1.8. Evolving Regulatory Guidelines

20. VALUE CHAIN ANALYSIS

21. EXECUTIVE INSIGHTS

22. APPENDIX 1: TABULATED DATA

23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료